Skip to main content
. 2019 Jun 11;20(11):2838. doi: 10.3390/ijms20112838
VTE venous thromboembolism
H&N head and neck
SCC squamous cell carcinoma
MPs microparticules
TF tissue factor
TFPI tissue factor pathway inhibitor
OSCC oral squamous cell carcinoma
ASCO American Society of Clinical Oncology
LMWH low molecular weight heparin
VKA vitamin K antagonist
tPA tissue plasminogen activators
uPA urokinase plasminogen activators
PAI plasminogen activator inhibitor
TAFI thrombin activated fibrinolysis inhibitor
ELISA enzyme-linked immunosorbent assays
TXA2 thromboxane A2
PGI2 prostacyclin
vWF von Willebrand factor
TM thrombomodulin
TNF tumor necrosis factor
IL interleukin
VEGF vascular endothelial growth factor
GM-CSF granulocyte-macrophage colony-stimulating factor
EGF epidermal growth factor
PDGF platelet-derived growth factor
TGFβ transforming growth factor